5TH INTERNATIONAL WORKSHOP • FROM PATHOLOGY TO TREATMENT, WHAT EVIDENCE IN INFLAMMATORY RHEUMATIC DISEASES? ARE THE HIGH-RISK INDIVIDUALS A NEW TREATM | ECM Finder